Infectious Diseases

1,796 Results

number of items to display at a time

Research

Sep 14, 2026

Misinformation and Conspiracies in COVID Times

The purpose of this chapter is to understand how social networking sites contributed to the infodemic during the pandemic and provide paths forward for combating online disaster-related disinformation and misinformation.
Research

Sep 14, 2026

Improving Public Health Laboratory Preparedness at European Union Level: Learning Points from Experiences During the COVID-19 Pandemic

This Perspective discusses how European Union (EU)-level action could support public health laboratories in preparing for future threats from respiratory infectious diseases.
Research

Sep 10, 2026

Mediators of the Effects of an HIV Prevention Advocacy Training Intervention on Prevention Advocacy Among Persons Living with HIV in Uganda

In a secondary analysis from a randomized controlled trial of a peer advocacy training intervention for PLWH, we examined mediators of intervention effects on HIV prevention advocacy across members of their social network.
Research

Aug 31, 2026

Patterns of Institutional Trust During COVID-19

To explore patterns of institutional trust among adults in the United States Gulf Coast region, we utilized data from the Survey of Trauma, Resilience, and Opportunity among Neighborhoods in the Gulf.
Research

Aug 31, 2026

Feasibility and Acceptability of a Compassion-Focused Program to Support Staff, Improve Workflows and Enhance the Clinic Environment in South African Primary Health Clinics with Low ART Retention

We used a positive deviance (PD) approach to develop a program called Connect designed to increase retention in HIV care by improving the staff and patient experience in South Africa.
Commentary

Aug 24, 2026

The Cyclospora Outbreak Was a Warning: Q&A with Saskia Popescu

Saskia Popescu is an epidemiologist by training and a policy researcher at RAND. In this Q&A, she discusses what the United States can do to prepare for future outbreaks like Cyclospora and other biological threats.
Research

Aug 24, 2026

Leveraging the Federal Select Agent Program to Oversee Nucleic Acids: Volume 2, Potential Benefits and Burdens, Recommendations, and Implementation Considerations

The increasing availability of synthetic genetic materials poses public health risks that may warrant regulation, but in deciding how to do so, it is also necessary to weigh the burdens on industry and the research community.
Research

Aug 24, 2026

Leveraging the Federal Select Agent Program to Oversee Nucleic Acids: Volume 1, Analysis of Opportunities to Control Genomes, Genes, and Gene Fragments Through the Federal Select Agent Program’s Authorities

The increasing availability of synthetic genetic materials may pose public health risks that may warrant regulation to ensure that certain materials are accessible only to researchers who will use them responsibly.
Research

Aug 21, 2026

Realising the 100 Days Mission: Accelerating Defence and Health Capabilities for Medical Countermeasures Readiness

This paper examines how the defence and health sectors can collaborate to advance the 100 Days Mission, drawing on capability mapping, stakeholder interviews, and a scenario-based exercise to identify priority joint capabilities.
Research

Aug 18, 2026

Personal Protective Equipment Prioritization and Demand: Using Occupational Characteristics to Understand Risk and Benefits

This report presents an occupation-based framework to estimate vital workforce size and personal protective equipment demand during a pandemic. An interactive dashboard supports scenario-based planning at the national, state, and regional levels.
Project

Aug 17, 2026

Realising the 100 Days Mission

RAND Europe identified where health and defence sectors can best work together to support the 100 Days Mission’s goal.
Research

Aug 12, 2026

Respirator Surge Manufacturing: Options to Ensure U.S. Small and Medium-Sized Enterprises Can Surge the Manufacturing of Respiratory Personal Protective Equipment

Small and medium-sized enterprises stepped up production of personal protective equipment in response to the coronavirus disease 2019 pandemic and could do so again if the conditions exist for them to remain viable, competitive, and surge ready.

First
Previous
Page 1 of 150
Next
Last

Infectious Diseases

Infectious Diseases

Related Topics

The Cyclospora Outbreak Was a Warning: Q&A with Saskia Popescu

Scaling Pandemic Preparedness and Response Cost Estimates for Disease Transmission Modes

Explore RAND’s Work on this Topic

Error

Misinformation and Conspiracies in COVID Times

Improving Public Health Laboratory Preparedness at European Union Level: Learning Points from Experiences During the COVID-19 Pandemic

Mediators of the Effects of an HIV Prevention Advocacy Training Intervention on Prevention Advocacy Among Persons Living with HIV in Uganda

Patterns of Institutional Trust During COVID-19

Feasibility and Acceptability of a Compassion-Focused Program to Support Staff, Improve Workflows and Enhance the Clinic Environment in South African Primary Health Clinics with Low ART Retention

The Cyclospora Outbreak Was a Warning: Q&A with Saskia Popescu

Leveraging the Federal Select Agent Program to Oversee Nucleic Acids: Volume 2, Potential Benefits and Burdens, Recommendations, and Implementation Considerations

Leveraging the Federal Select Agent Program to Oversee Nucleic Acids: Volume 1, Analysis of Opportunities to Control Genomes, Genes, and Gene Fragments Through the Federal Select Agent Program’s Authorities

Realising the 100 Days Mission: Accelerating Defence and Health Capabilities for Medical Countermeasures Readiness

Personal Protective Equipment Prioritization and Demand: Using Occupational Characteristics to Understand Risk and Benefits

Realising the 100 Days Mission

Respirator Surge Manufacturing: Options to Ensure U.S. Small and Medium-Sized Enterprises Can Surge the Manufacturing of Respiratory Personal Protective Equipment

Oops! An unexpected error has occurred.

RAND Headquarters

U.S. research divisions

International research divisions

Infectious Diseases

Infectious Diseases

Related Topics

The Cyclospora Outbreak Was a Warning: Q&A with Saskia Popescu

Scaling Pandemic Preparedness and Response Cost Estimates for Disease Transmission Modes

Explore RAND’s Work on this Topic

Error

Misinformation and Conspiracies in COVID Times

Improving Public Health Laboratory Preparedness at European Union Level: Learning Points from Experiences During the COVID-19 Pandemic

Mediators of the Effects of an HIV Prevention Advocacy Training Intervention on Prevention Advocacy Among Persons Living with HIV in Uganda

Patterns of Institutional Trust During COVID-19

Feasibility and Acceptability of a Compassion-Focused Program to Support Staff, Improve Workflows and Enhance the Clinic Environment in South African Primary Health Clinics with Low ART Retention

The Cyclospora Outbreak Was a Warning: Q&A with Saskia Popescu

Leveraging the Federal Select Agent Program to Oversee Nucleic Acids: Volume 2, Potential Benefits and Burdens, Recommendations, and Implementation Considerations

Leveraging the Federal Select Agent Program to Oversee Nucleic Acids: Volume 1, Analysis of Opportunities to Control Genomes, Genes, and Gene Fragments Through the Federal Select Agent Program’s Authorities

Realising the 100 Days Mission: Accelerating Defence and Health Capabilities for Medical Countermeasures Readiness

Personal Protective Equipment Prioritization and Demand: Using Occupational Characteristics to Understand Risk and Benefits

Realising the 100 Days Mission

Respirator Surge Manufacturing: Options to Ensure U.S. Small and Medium-Sized Enterprises Can Surge the Manufacturing of Respiratory Personal Protective Equipment

Oops! An unexpected error has occurred.